European Dividend aristocrat and French drugmaker Sanofi (SAN.PA) reported an EPS of 5.99 euros, up 6.8% Net sales were 36.13 billion euros, up 4.8% as reported, and up 2.8%, including vaccine sales of 5.73 billion euros, up 9.3% and therefore in line with the average growth rate expected between 2018 and 2025.
Sanofi’s board of directors has proposed a dividend of €3.15, representing the 26th consecutive annual increase. An increase of 2.6% compared to the previous dividend of €3.07.
